BioSpace News Archive

SPECIAL EVENT: OUR EYES ARE EXPERIENCING MUCH HARSHER CONDITIONS THAN WE IMAGINE

Latest Round Brings Total Funding to $22.5 Million; Resources Will Allow Company to Expand Global Capabilities; Investment Underscores Company’s Potential to Transform Education, Prepare Students for Future Success

BLA Includes Data From Pivotal Phase 3 Studies of More Than 11,000 Patients

Thermo Fisher Scientific Inc. announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per common share, payable on October 15, 2018, to shareholders of record as of September 17, 2018.

The popular German TV show, Nano, on 3 SAT, which some liken to America’s “60 Minutes”, recently presented as its lead segment an interview with Leslie Norins, MD, PhD, CEO of Alzheimer’s Germ Quest, Inc. (AGQ), and his wife Rainey, Vice President, discussing the possibility that germs might play a role in the causation of Alzheimer’s disease (AD).

alska® has been accepted into the Founders Program at Station F in Paris, France.

Advaxis, Inc. announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on the Company’s Investigational New Drug (IND) application for its Phase 1/2 study of axalimogene filolisbac (AXAL)

The Community Health & Wellness Festival, held at the Xavier University Student Center in New Orleans on July 5, provided free health screenings and education to more than 800 area residents, ranging in age from two to over 90 years old.

According to data published by Marijuana Business Daily, cannabis retail sales continue to grow year-over-year, as new markets emerge, and more states legalize medical and recreational cannabis.

Medical Marketing & Media (MM&M) releases its annual list of top healthcare agencies, places Continuum Clinical at #59.